Company Filing History:
Years Active: 2008
Title: The Innovations of Tom Thamann
Introduction
Tom Thamann is an accomplished inventor based in Vicksburg, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. His work has led to the creation of innovative compounds that have the potential to impact medical treatments.
Latest Patents
Tom Thamann holds a patent for "Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors." This invention relates to polymorphs of the 3-pyrrole substituted 2-indolinone compound 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide. This patent showcases his expertise in creating novel chemical compounds that could lead to advancements in therapeutic applications.
Career Highlights
Tom Thamann is associated with Pharmacia & Upjohn Company, where he has been instrumental in research and development. His work at the company has allowed him to explore various innovative solutions in the pharmaceutical industry. His dedication to his field is evident through his successful patent and ongoing research efforts.
Collaborations
Throughout his career, Tom has collaborated with notable colleagues, including Changquan Sun and Todd P Foster. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tom Thamann is a notable inventor whose work in the pharmaceutical field has led to significant advancements. His patent for polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors exemplifies his innovative spirit and commitment to improving medical treatments.